An overview of clinical trials investigating BTK inhibitors and degraders in MCL

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=Zbw40G0fgeo

Michael Wang, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of promising clinical trials exploring BTK inhibitors in ...

Speaker: Michael Wang, Institution: The University of Texas MD Anderson Cancer Center, Event: SOHO 2024, Format: Interview, Subject: Mantle Cell Lymphoma, Medicines: Ibrutinib, Medicines: Acalabrutinib, Medicines: Zanubrutinib, Medicines: BTK inhibitors, Medicines: BTK degraders, Medicines: Pirtobrutinib, Subject: Non-Hodgkin Lymphoma, Subject: Lymphoma, MCL, clinical trials, Field: Treatment, Field: Trial Updates
#############################